Hereditary blindness caused by a progressive degeneration of the light-sensing cells in the eye, the photoreceptors, affects millions of people worldwide.
Although the light-sensing cells are lost, cells in deeper layers of the retina, which normally cannot sense light, remain intact. A promising new therapeutic approach based on a technology termed “optogenetics” is to introduce light-sensing proteins into these surviving retinal cells, turning them into “replacement photoreceptors” and thereby restoring vision. However, several factors limit the feasibility of a clinical optogenetic therapy using traditional light-sensitive proteins, as they require unnaturally high and potentially harmful light intensities and employ a foreign signaling mechanism within the target retinal cells.
New research publishing May 7th in the Open Access journal PLOS Biology from van Wyk and colleagues demonstrates how optogenetic proteins can be tailored to bring this promising technology closer to medical application. “We were asking the question, ‘Can we design light-activatable proteins that gate specific signaling pathways in specific cells?’, in other words, can the natural signaling pathways of the target cells be retained and just modified in a way to be turned on by light instead of a neurotransmitter released from a preceding neuron?” says Dr. Sonja Kleinlogel, corresponding author of the paper (whose research group is based at the University of Berne, Switzerland). The aim of molecular engineering was to achieve maximal compatibility with native signaling whilst retaining all the advantages of traditional optogenetic proteins, such as fast kinetics and resistance to bleaching by light.
The novel light-sensing protein, termed Opto-mGluR6, is a chimeric protein composed of the light-sensing domains of the retinal photopigment melanopsin and the ON-bipolar cell-specific metabotropic glutamate receptor mGluR6, which is naturally activated by glutamate released from the photoreceptors and amplifies the incoming signal through a coupled intracellular enzymatic pathway. Unlike rhodopsin, for example, the “light antenna” of melanopsin is resistant to bleaching. In other words, the response strength of Opto-mGluR6 never attenuates, no matter how often and hard the protein is hit by light. Moreover, since Opto-mGluR6 is a chimeric protein consisting of two “local” retinal proteins it is also likely to be “invisible” to the immune system, another improvement over traditional optogenetic proteins.
In their study van Wyk and colleagues targeted the retinal ON-bipolar cells, which naturally receive direct input from the photoreceptors. Targeting the surviving cells at the top end of the visual cascade has the advantage that signal computation of the retina is maximally utilized. Turning the native chemical receptor (mGluR6) into a light-activated receptor ensures conservation of native signaling within the ON-bipolar cells, conferring high light-sensitivity and fast “normal” responsiveness. In their study they show proof-of-principle that mice suffering from Retinitis pigmentosa can be treated to regain daylight vision. “The new therapy can potentially restore sight in patients suffering from any kind of photoreceptor degeneration” says Dr. Kleinlogel, “for example also those suffering from severe forms of age-related macular degeneration, a very common disease that affects to some degree about one in every 10 people over the age of 65”.
“The major improvement of the new approach is that patients will be able to see under normal daylight conditions without the need for light intensifiers or image converter goggles”
The Latest on: Optogenetics
via Google News
The Latest on: Optogenetics
- Optogenetics helps show what happens in brain cells during fear-memory formationon January 31, 2020 at 12:08 pm
Researchers at the RIKEN Center for Brain Science (CBS) used optogenetics to help visualize these dynamics in the living mouse brain, observing fast and slow molecular pathways that support memory ...
- Sculpting Light: Designing Optimal All-Optical Experimentson January 29, 2020 at 12:09 pm
Advances in optics and optogenetics make it possible to simultaneously stimulate and record from dozens of neurons with near single-cell precision. Michael Häusser Last summer, Stanford University ...
- Light-Inducible Recombinases for Bacterial Optogeneticson January 23, 2020 at 8:10 pm
Department of Biomedical Engineering, Boston University, Boston, Massachusetts 02215, United States Biological Design Center, Boston University, Boston, Massachusetts 02215, United States Article ...
- Optogenetics Market 2020: Share and Size Analysis with Leading Vendors, Growth Drivers, Trends, Forecast 2029on January 16, 2020 at 10:37 pm
Jan 17, 2020 (WiredRelease via COMTEX) -- A recent market research analysis titled, Optogenetics Market offers insightful information to the clients escalating their basic leadership size explores ...
- Neuroscience Lab Coordinator (m/f/d) - GenTSV Projektleiter, Optogenetics and Optical Imagingon January 13, 2020 at 4:00 pm
Since we will conduct experiments using optogenetics and genetically-encoded calcium and voltage indicators, our neurobiology labs are classified as genetic engineering (Gentechnik) facilities. The ...
- Global Optogenetics Actuators and Sensors Market by Top Key Vendors, Trends, Sales, Supply, Demand, Analysis and Forecasts to 2025on January 10, 2020 at 3:52 am
The“Optogenetics Actuators and Sensors Market: by product type (actuators and sensors), and disease type (retinal disorders, parkinson’s disease, anxiety & depression, autism, schizophrenia ...
- Engineers develop a less invasive way to study the brainon December 19, 2019 at 7:18 am
Developed in part at Stanford, optogenetics is based on the idea that scientists can genetically modify cells, such as neurons, to make some of their functions switch on and off with visible light.
- FRET-assisted photoactivation of flavoproteins for in vivo two-photon optogeneticson September 9, 2019 at 8:12 am
Optical dimerizers have been developed to untangle signaling pathways, but they are of limited use in vivo, partly due to their inefficient activation under two-photon (2P) excitation. To overcome ...
- LED Array Implant Illuminates the Future for Optogenetics Studieson August 26, 2019 at 5:00 pm
Using optogenetics, scientists can selectively activate or deactivate neurons by illuminating them with light, allowing researchers to perform fine-grained cause-and-effect studies between brain ...
- Optogenetics: Electronic Chip Mimics The Way The Brain Stores And Loses Informationon July 16, 2019 at 7:58 am
Optogenetics biotechnology, using light to manipulate neurons so that they can be turned on or off, has led to a device that replicates the way the brain stores and loses information. The new chip is ...
via Bing News